NCT06989814View on ClinicalTrials.gov

Smart Measurement of Circulating Tumor DNA

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 16, 2025

Primary Completion Date

October 1, 2026

Study Completion Date

February 1, 2027

Conditions
Colorectal NeoplasmsColorectal Neoplasms MalignantColorectal Neoplasms, Hereditary NonpolyposisHereditary Nonpolyposis Colon Cancer
Interventions
DIAGNOSTIC_TEST

Blood Product

An (extra) blood test will be done on participants. This will be analyzed for circulating tumor DNA (ctDNA) via a multi-omics approach.

Trial Locations (2)

2333ZG

NOT_YET_RECRUITING

Leiden University Medical Center, Leiden

3015GD

RECRUITING

Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Dutch Cancer Society

OTHER

collaborator

Leiden University Medical Center

OTHER

lead

Erasmus Medical Center

OTHER